Intech Investment Management LLC Invests $1.28 Million in Oscar Health, Inc. (NYSE:OSCR)

Intech Investment Management LLC bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 60,465 shares of the company's stock, valued at approximately $1,282,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. KBC Group NV grew its stake in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after buying an additional 1,328 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in Oscar Health in the second quarter valued at approximately $78,000. Quest Partners LLC purchased a new stake in shares of Oscar Health during the second quarter valued at approximately $93,000. Optimum Investment Advisors acquired a new position in shares of Oscar Health during the third quarter worth $142,000. Finally, Amalgamated Bank boosted its stake in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after purchasing an additional 1,458 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the business's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. The trade was a 3.99 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of Oscar Health stock in a transaction dated Monday, November 11th. The stock was bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 194,569 shares worth $3,433,319. 25.11% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

OSCR has been the topic of a number of recent analyst reports. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target on the stock. Finally, Piper Sandler restated an "overweight" rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Oscar Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $22.93.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded up $0.55 on Wednesday, reaching $16.83. 1,790,670 shares of the company's stock were exchanged, compared to its average volume of 3,417,107. Oscar Health, Inc. has a fifty-two week low of $7.29 and a fifty-two week high of $23.79. The business's 50-day moving average is $17.68 and its two-hundred day moving average is $18.11. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $4.16 billion, a price-to-earnings ratio of -271.29 and a beta of 1.67.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health's quarterly revenue was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.29) earnings per share. As a group, equities research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.